EU authorities agree new measures to support availability of medicines used in the COVID-19 pandemic

The EMA is placing measures aimed at mitigating supply disruptions especially for medicines used in intensive care units such as anaesthetics, antibiotics and muscle relaxants as well as medicines used off-label for COVID-19.


European Medicines Agency